Very Low Birth Weight Infant
0
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Human BioSciencesFlexiMitt
Baxter InternationalReady-to-Use Parenteral Nutrition
Angeles Therapeuticscord milking
Clinical Trials (3)
Total enrollment: 322 patients across 3 trials
Flexible Electronics for Early Assessment
Start: Aug 2017Est. completion: May 202133 patients
N/ACompleted
Clinical Outcomes of Ready-to-Use Parenteral Nutrition in Low Birth Weight Newborns in Colombia 2017-2023
Start: Mar 2017Est. completion: Mar 2023284 patients
N/ACompleted
Cord Milking Impacts Neurodevelopmental Outcomes in Very Low Birth Weight Infants
Start: May 2016Est. completion: May 20185 patients
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.